Skip to content

Clinical trials

Fibrocystic Breast Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fibrocystic Breast Disease Country / region: United States Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20091
20101
20201
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
FemmePharma Global Healthcare, Inc.2
Mayo Clinic1
Symbollon Pharmaceuticals1
University of Florida1
Washington University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fibrocystic Breast Disease6
Breast Neoplasms2
Mastodynia2
Breast Carcinoma In Situ1
Carcinoma, Intraductal, Noninfiltrating1
Colonic Neoplasms1
Colorectal Neoplasms1
Cysts1
Fibrosis1
Gastrointestinal Diseases1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.